NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies.

Author(s): Schmidt AJ, Kee ST, Sze DY, Daniel BL, Razavi MK, Semba CP, Dake MD

Publication: J Vasc Interv Radiol, 1999, Vol. 10, Page 1323-9

PubMed ID: 10584646 PubMed Review Paper? No

Purpose of Paper

This paper compared the diagnostic sensitivity, specificity, and accuracy of magnetic resonance (MR)-, computed tomography (CT)- and ultrasound (US)-guided liver biopsies.

Conclusion of Paper

MR-, CT-, and US-guided liver biopsies were comparable in sensitivity, specificity, accuracy and false negative rates.

Studies

  1. Study Purpose

    This study compared the diagnostic sensitivity, specificity, and accuracy of MR-, CT- and US-guided liver biopsies. Sixty-four MR-guided biopsies were performed on 60 patients with lesions difficult to visualize by CT or US using an 18-gauge (G) stabilization needle and a 21-G aspiration needle. CT-guided biopsies (30 patients) and US-guided biopsies (18 patients) were performed using a 19-G stabilization needle and a 21-G aspiration or 20-G core biopsy needle. The biopsy processing and analysis methods used were not discussed. The mean sizes of the lesions biopsied under the three different guidance methods were comparable. 

    Summary of Findings:

    MR-, CT-, and US-guided liver biopsies had comparable sensitivity (75%, 77% and 79%, respectively), specificity (100%, all), and accuracy (80%, 80% and 83%, respectively). A comparable number of false negatives occurred in a comparable number of MR-, CT-, and US-guided biopsies (13/64, 6/30 and 3/18, P=0.96). A significantly lower mean number of passes were conducted for US-guided biopsies (4.4) than CT (6.8, P=0.01), but the mean number of passes were comparable for MR-guided (5.3) biopsies and US- or CT- guided biopsies.

    Biospecimens
    Preservative Types
    • Other Preservative
    • Ethanol
    Diagnoses:
    • Neoplastic - Benign
    • Neoplastic - Sarcoma
    • Neoplastic - Lymphoma
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Morphology Light microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Method of cell acquisition MR-guided biopsy
    CT-guided biopsy
    US-guided biopsy

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...